Eli Lilly Must Pay Royalties In Diabetes Drug Row, Judge Says
By Andrew Karpan · October 20, 2021, 8:53 PM EDT
A federal judge has determined that Eli Lilly owes an Arizona company a portion of the billions of dollars in sales from its insulin brands, citing a 1992 royalty agreement that...
To view the full article, register now.